Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development
Clinical trial NCT03780673 · COMPLETED
Trial details
- NCT number
- NCT03780673
- Sponsor
- Judit Pich
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-03
- Primary completion
- 2022-12-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.